The cardiovascular device market is a crucial part of the larger medical device industry. Here, we break down which categories within the space are attracting the most attention based on patent applications and earnings calls mentions.
The cardiovascular device market reached nearly $42B in 2017 and is projected to increase to roughly $59B by 2022.
This is a wide-ranging medical device category that includes everything from diagnostics to implantable devices. It provides medical or surgical solutions to diseases affecting the heart and/or vascular system (e.g. blood vessels).
Track all the medical device startups in this brief and many more on our platform
Startups are working on connected devices, next-gen prosthetics, and robotics aimed at the medical field. Look for Medical Devices in the Collections tab.Track medical device startups
Revenue breakdowns from big medical device companies indicate the market’s continued reliance on cardiovascular as a mainstay in the device industry.
For example, Medtronic disclosed that its Cardiac & Vascular Group (CVG) reported $11.4B out of the total reported net sales of $30B —the highest of its 4 main divisions — in its last 10-K filing (fiscal year ending on 4/27/18)
Using CB Insights’ Patent Analysis and Earnings Transcript tools, we take a look at which traditional cardiovascular diseases & devices are generating the most interest and innovation. We also look at which cardiovascular diseases may be becoming higher priorities.